Disease/Infection News

RSS

Study provides novel insight into the evolution of hepatitis A virus and how it spreads to humans

Researchers at the University of North Carolina at Chapel Hill are part of an international team led by the University of Bonn, Germany, who have found a link between the origin of hepatitis A virus (HAV) and small mammals.

4 Nov 2015

HIV, Ebola appear to be of animal origin

The hepatitis A virus can trigger acute liver inflammation which generally has a mild course in small children but which can become dangerous in adults.

3 Nov 2015

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

The study showed that about thirty percent to maybe half of the leading causes of death in the world are preventable. These are risk factors that you could manage and thus you could prevent a lot of premature deaths.

3 Nov 2015

Delay in hospital admittance increases risk of death for Ebola patients during epidemics

A retrospective study of Ebola epidemics in the Democratic Republic of Congo (DRC) suggested that each day of delay in hospital admittance was associated with an 11% increased risk of death for Ebola patients during epidemics.

3 Nov 2015

Loughborough researchers secure £545,000 to help tackle Antimicrobial Resistance

Researchers at Loughborough University have secured £545,000 to help tackle growing resistance to antibiotics.

3 Nov 2015

Study identifies potential new approaches to curing parasitic diseases

A study in the Proceedings of the National Academy of Sciences shows that some forms of the single celled parasites, Trypanosoma brucei and Toxoplasma gondii behave like cancer cells.

3 Nov 2015

Experts call on U.S. and Mexican governments to reduce risk of Chagas disease

Chagas disease -- the third most common parasitic infection in the world -- affects approximately 7.5 million people, mostly in Latin America. To help reduce outbreaks of this disease in their countries, the United States and Mexican governments should implement a range of programs as well as fund research for the development of Chagas vaccines and treatments, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.

3 Nov 2015

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline.

3 Nov 2015

Researchers use genomic techniques to show why different strains of Salmonella infect particular animal species

It's called bird flu for a reason. Particular characteristics about the influenza virus known as H5N1 allow it to primarily affect avifauna, though in some worrying cases the disease has been passed to humans.

3 Nov 2015

New initiative launched to accelerate search for effective HIV vaccine

A new 23 million euro initiative to accelerate the search for an effective HIV vaccine begins today. Financed by the European Commission, the European AIDS Vaccine Initiative (EAVI2020) brings together leading HIV researchers from public organisations and biotech companies from across Europe, Australia, Canada and the USA in a focused effort to develop protective and therapeutic HIV vaccines.

2 Nov 2015

Personal anxiety, mass media coverage interact to determine what people remember about specific disease

The health facts presented by mass media in the midst of a disease outbreak are likely to influence what we remember about the disease -- new research suggests that the same mass media coverage may also influence the facts that we forget.

2 Nov 2015

Self-disseminating vaccines could prevent EID transmission from animals to humans

The 2014/2015 Ebola outbreak in West Africa shone the spotlight not only on the unpreparedness of local health services and science to deal with the pandemic, but also on the phenomenon of emerging infectious diseases (EIDs).

2 Nov 2015

Around 20% of ethnic school girls not vaccinated against HPV

Around 20 per cent of girls from ethnic minority backgrounds are not being vaccinated against the Human Papilloma Virus (HPV) because they feel they don't need to have it, according to a Cancer Research UK survey presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool*.

2 Nov 2015

Coating implants with tissue plasminogen activator can prevent biofilm-related infections

Biofilms--mats of bacteria similar to the plaque that grows on teeth--frequently coat the surfaces of catheters, and of various medical implants and prostheses, where they can threaten lives or lead to failure of the implants. Antibiotics are impotent against biofilms.

31 Oct 2015

Blocking calcium-signaling pathway could inhibit Ebola virus and other sources of deadly infections

The Ebola virus acts fast. The course of infection, from exposure to recovery, or death, can take as little as two weeks. That may not leave enough time for the immune system to mount an effective response.

31 Oct 2015

First patient of U.S. phase 1 trial treated with Genticel’s GTL001 candidate for HPV 16/18 infections

Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the first patient of the U.S. phase 1 clinical trial has been vaccinated with GTL001, the company’s first-in-class therapeutic vaccine candidate against HPV 16/18 infections.

31 Oct 2015

Disease/Infection News

Study provides novel insight into the evolution of hepatitis A virus and how it spreads to humans

HIV, Ebola appear to be of animal origin

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

Delay in hospital admittance increases risk of death for Ebola patients during epidemics

Loughborough researchers secure £545,000 to help tackle Antimicrobial Resistance

Study identifies potential new approaches to curing parasitic diseases

Experts call on U.S. and Mexican governments to reduce risk of Chagas disease

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

Researchers use genomic techniques to show why different strains of Salmonella infect particular animal species

New initiative launched to accelerate search for effective HIV vaccine

Personal anxiety, mass media coverage interact to determine what people remember about specific disease

Self-disseminating vaccines could prevent EID transmission from animals to humans

Around 20% of ethnic school girls not vaccinated against HPV

Coating implants with tissue plasminogen activator can prevent biofilm-related infections

Blocking calcium-signaling pathway could inhibit Ebola virus and other sources of deadly infections

First patient of U.S. phase 1 trial treated with Genticel’s GTL001 candidate for HPV 16/18 infections

New anti-malarial ‘biobricks' could pave way for easier, cost-effective production of artemisinin drug

Johns Hopkins doctors urge people to get vaccinated against influenza virus

UTMB scientists work with InBios International to develop novel diagnostic test for chikungunya

Loyola pediatrician reveals signs and symptoms of childhood rashes

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News